Top of page
Global Site Navigation

Research

Local Section Navigation
You are here: Main Content

The EXPAN trial

Purpose: A pilot randomised controlled trial (RCT) to examine the feasibility and efficacy of a supervised, multicomponent exercise program in patients with localised pancreatic cancer undergoing preoperative therapy.

Inclusion Criteria:

  • Age ≥18 years.
  • Waiting to start or within 8 weeks of induction chemotherapy .
  • Approved by their treating oncologist to participate in the trial.

Exclusion criteria:

  • Recurrent pancreatic cancer with or without exposure to previous chemotherapy.
  • Having undergone treatments for another primary cancer within the last 12 months, or another ongoing active primary malignancy.
  • Anticipating undergoing major surgery for non-cancer diseases within the next 6 months.
  • Any musculoskeletal, cardiovascular or neurological disorder that could put patients at risk during exercise testing and training.
  • Having participated in planned, individualised and supervised exercise training for ≥2 days/week in the previous month.
Skip to top of page